Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial

Summary

Evaluate the efficacy and safety of neoadjuvant chemotherapy (NAC) with albumin-bound paclitaxel and carboplatin followed by chemoradiation therapy (CRT) for stage IIIC cervical cancer patients with carcinoma \>4 cm in greatest dimension and/or lymph node \>2cm in short axis.

Eligibility

Inclusion Criteria:

1. pathologically comfirmed : squamous cell, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix；
2. FIGO (2018 International Federation of Gynecology and Obstetrics) stage IIIC with carcinoma \>4 cm in greatest dimension and/or lymph node \>2 cm in short axis at initial diagnosis.
3. age 18 to 70 years；
4. Eastern Cooperative Oncology Group performance status 0 to 2；
5. adequate organ function.

Exclusion Criteria:

1\. not at initial diagnosis; 2. with other kind of tumor.

\-

Conditions4

Interventions2

Related trials

• A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors — Shanghai Junshi Bioscience Co., Ltd.
• AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer — Henan Cancer Hospital
• Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC — The First Affiliated Hospital of Bengbu Medical University
• Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer — Tianjin Medical University Cancer Institute and Hospital
• Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma — Fudan University
• Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer — Fujian Cancer Hospital
• Chemoradiotherapy in Unresectable Esophageal Cancer — Cancer Institute and Hospital, Chinese Academy of Medical Sciences
• HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors — Chinese PLA General Hospital

Browse More Trials